Geneos Wealth Management’s BNY Mellon US Mid Cap Core Equity ETF BKMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.67M Buy
208,545
+3,930
+2% +$150K 0.18% 134
2025
Q4
$7.43M Buy
204,615
+6,204
+3% +$225K 0.18% 143
2025
Q3
$7.18M Buy
198,411
+6,504
+3% +$230K 0.18% 142
2025
Q2
$6.55M Sell
191,907
-82,731
-30% -$2.65M 0.16% 157
2025
Q1
$8.75M Buy
274,638
+185,106
+207% +$6.27M 0.13% 193
2024
Q4
$3.03M Buy
89,532
+222
+0.2% +$7.75K 0.11% 213
2024
Q3
$3.04M Buy
89,310
+5,214
+6% +$169K 0.12% 209
2024
Q2
$2.64M Buy
84,096
+4,737
+6% +$149K 0.12% 203
2024
Q1
$2.62M Buy
79,359
+8,772
+12% +$271K 0.12% 207
2023
Q4
$2.13M Buy
70,587
+4,818
+7% +$132K 0.11% 220
2023
Q3
$1.76M Buy
65,769
+2,439
+4% +$68.4K 0.09% 232
2023
Q2
$1.79M Buy
63,330
+702
+1% +$18.8K 0.09% 228
2023
Q1
$1.7M Buy
62,628
+1,419
+2% +$38.8K 0.1% 220
2022
Q4
$1.6M Buy
61,209
+13,794
+29% +$359K 0.1% 208
2022
Q3
$1.14M Buy
47,415
+16,521
+53% +$438K 0.08% 233
2022
Q2
$784K Buy
30,894
+19,302
+167% +$530K 0.04% 390
2022
Q1
$348K Buy
11,592
+4,884
+73% +$144K 0.01% 630
2021
Q4
$212K Buy
6,708
+5,208
+347% +$162K 0.01% 838
2021
Q3
$44K Hold
1,500
﹤0.01% 1548
2021
Q2
$44K Buy
1,500
+750
+100% +$21.9K ﹤0.01% 1540
2021
Q1
$21K Hold
750
﹤0.01% 2050
2020
Q4
$20K Buy
+750
New +$18.1K ﹤0.01% 1898

Other funds holding BKMC

Geneos Wealth Management's BKMC Position: Q1 2026 in Review

Geneos Wealth Management increased its BNY Mellon US Mid Cap Core Equity ETF (BKMC) stake by 1.9% in Q1 2026, buying an estimated $150K and bringing the position to 208,545 shares worth $7.67M. The position accounts for 0.18% of the portfolio, ranked #134.

Geneos Wealth Management first reported a position in BKMC in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.75M in Q1 2025. 38 funds tracked by Wall St. Rank hold BKMC as of Q1 2026.

  • Geneos Wealth Management held 208,545 shares of BNY Mellon US Mid Cap Core Equity ETF worth $7.67M as of Q1 2026.
  • Geneos Wealth Management bought 3,930 BNY Mellon US Mid Cap Core Equity ETF shares in Q1 2026, an estimated $150K.
  • BNY Mellon US Mid Cap Core Equity ETF made up 0.18% of Geneos Wealth Management's portfolio in Q1 2026, its #134 holding.
  • Geneos Wealth Management first reported a position in BNY Mellon US Mid Cap Core Equity ETF in Q4 2020 and has held it in 22 quarters since.
  • Geneos Wealth Management's BNY Mellon US Mid Cap Core Equity ETF position peaked at $8.75M in Q1 2025.
  • 38 funds tracked by Wall St. Rank held BNY Mellon US Mid Cap Core Equity ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.